Effectdossier · gearchiveerd kwartaal
CTMX
CytomX Therapeutics, Inc. · Healthcare · Biotechnology
49Gevolgde houders
-1Δ houders
71.30MGehouden aandelen
$303.77MGerapporteerde waarde
+0Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders -2.0% ·
aandelenstroom +23.5% ·
netto nieuwe posities -2.0%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | +11 | 136.41M | $511.64M | +18 | −7 |
| Q1 2026 | 64 | +15 | 111.19M | $522.57M | +20 | −5 |
| Q4 2025 | 49 | -1 | 71.30M | $303.77M | n/a | −1 |
| Q3 2025 | 14 | 0 | 41.38M | $131.99M | n/a | n/a |
| Q2 2025 | 11 | 0 | 36.17M | $82.10M | n/a | n/a |
| Q1 2025 | 8 | +1 | 8.01M | $5.09M | +1 | n/a |
| Q4 2024 | 7 | 0 | 9.00M | $9.27M | +1 | −1 |
| Q3 2024 | 6 | 0 | 8.17M | $9.64M | n/a | n/a |
| Q2 2024 | 6 | n/a | 7.95M | $9.70M | n/a | n/a |
Wie het bezit · Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 24.69M | +60.4% | $105.17M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 2 | The Vanguard Group ✦ (passief) | 8.48M | -5.3% | $36.11M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 3 | Point72 Asset Management ✦ | 5.19M | +27.6% | $22.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passief) | 5.14M | +697.1% | $21.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | Balyasny Asset Management L.P. | 3.87M | n/a | $16.50M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Financial Engines Advisors L.L.C. | 3.83M | n/a | $16.31M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.67M | +54.0% | $15.63M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 8 | Goldman Sachs Group ✦ | 2.46M | +449.6% | $10.48M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 1.56M | +113.9% | $6.65M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 1.53M | -2.8% | $6.50M | 0.0% | ▼ Trim | 7 | SEC ↗ ×2 |
| 11 | Dimensional Fund Advisors Lp | 1.29M | n/a | $5.49M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 12 | Marshall Wace ✦ | 1.16M | +4.7% | $4.93M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 13 | Qube Research & Technologies Ltd | 1.06M | n/a | $4.52M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Susquehanna International Group, Llp | 981.60K | n/a | $4.18M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Bank Of America Corp /De/ | 876.30K | n/a | $3.73M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 16 | Jane Street Group, Llc | 607.22K | n/a | $2.59M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Assenagon Asset Management S.A. | 592.70K | n/a | $2.52M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | First Trust Advisors Lp | 423.17K | n/a | $1.80M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Northern Trust Corp | 415.18K | n/a | $1.77M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 401.19K | +25.6% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 21 | UBS Group AG | 370.74K | n/a | $1.58M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 22 | Citadel Advisors ✦ | 342.30K | -81.0% | $1.46M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 23 | Barclays Plc | 336.52K | n/a | $1.43M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 24 | Bank of New York Mellon Corp | 328.25K | n/a | $1.40M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 25 | Raymond James Financial Inc | 316.97K | n/a | $1.35M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 26 | Millennium Management ✦ | 289.65K | -79.1% | $1.23M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 27 | Ameriprise Financial Inc | 229.60K | n/a | $988,976 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Sei Investments Co | 124.12K | n/a | $528,768 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | LPL Financial LLC | 113.44K | n/a | $483,254 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Canada Pension Plan Investment Board | 104.20K | n/a | $443,892 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citigroup Inc | 96.33K | n/a | $410,349 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Hrt Financial Lp | 71.87K | n/a | $306,000 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Charles Schwab Investment… | 68.69K | n/a | $292,607 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Squarepoint Ops LLC | 49.90K | n/a | $212,561 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Tidal Investments LLC | 45.76K | n/a | $194,950 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Hsbc Holdings Plc | 24.46K | n/a | $104,200 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 37 | JPMorgan Chase ✦ | 24.36K | -24.6% | $103,786 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 38 | Simplex Trading, Llc | 24.05K | n/a | $102,457 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Mariner, LLC | 22.18K | n/a | $94,487 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Invesco Ltd. | 21.98K | n/a | $93,618 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Osaic Holdings, Inc. | 19.41K | n/a | $82,686 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 42 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 15.96K | n/a | $66,389 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Victory Capital Management Inc | 14.72K | n/a | $62,716 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Bank Of Nova Scotia | 13.66K | n/a | $58,196 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Mirae Asset Global Investments Co.… | 8.23K | n/a | $35,073 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Wells Fargo & Company/Mn | 6.61K | n/a | $28,137 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 47 | Bnp Paribas Financial Markets | 2.83K | n/a | $12,034 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Daiwa Securities Group Inc. | 564 | n/a | $2,000 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Royal Bank Of Canada | 214 | n/a | $1,000 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Renaissance Technologies | $8.12M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 178 houders, 193.14M aandelen, $906.86M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2025 ·
Methodologie ·
Verkrijg dit via de API